GRG's Center For Experiential Learning

Advanced melanoma care in the U.S. has evolved rapidly with the rise of immunotherapies, targeted treatments, and precision medicine. Drawing on insights from U.S. oncologists, dermatologists, and payers, this blog examines how clinicians are navigating treatment sequencing, biomarker-driven decisions, and access challenges in real-world practice.